Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Global Ovarian Cancer Diagnostics and Therapeutics Market (2017-2022) - Segmented by Type of Cancer & Geography - Research and Markets

Research and Markets
Posted on: 04 Sep 17

The "Global Ovarian Cancer Diagnostics and Therapeutics Market - Segmented by Type of Cancer and Geography 2017 - 2022" report has been added to Research and Markets' offering.

The global market for ovarian cancer diagnostics and therapeutics accounted for USD 1,106 million in 2015 and is expected to grow at a CAGR of 10-16% by 2020.

Ovarian cancer is caused by an uncontrollable cell growth in the ovarian tissue. It is a growing concern as it is one of the most common causes of death in women across the globe. Thereby, the need to develop new medication and therapies for the effective treatment of this disease, and new methods for the timely diagnosis of ovarian cancer, is increasing. Thus, the market for ovarian cancer diagnostics and therapeutics is at a stage of huge development.

North America dominates the global market for ovarian cancer diagnostics and therapeutics. Europe is the second largest market, after North America. Asia-Pacific is expected to show high growth rates in the next few years in this market due to the large aging population and high prevalence of ovarian cancer. China and India are expected to be the fastest growing ovarian cancer markets in the Asia-Pacific region.

Market Drivers:

  • Increasing incidences of ovarian cancer worldwide
  • Increasing population of aged women
  • Greater use of combination therapies for the treatment
  • Increase in healthcare expenditure
  • Increased government funding
  • Increasing healthcare awareness

Market Restraints:

  • Launch of generic drugs
  • Patent expiry of key drugs

Companies Mentioned:

  • Amgen, Inc.
  • Eli Lilly and Company
  • Celgene Corporation
  • Clovis Oncology, Inc.
  • Novartis AG
  • Threshold Pharmaceuticals, Inc.
  • Incyte Corp
  • Merrimack Pharmaceuticals Inc.
  • Roche Ltd
  • NewLink Genetics

Key Topics Covered:

1. Introduction

2. Executive Summary

3. Market Overview

4. Porters Five Force Analysis

5. Market Segmentation

6. Competitive Landscape

7. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/8gldkx/global_ovarian

View source version on businesswire.com: http://www.businesswire.com/news/home/20170904005239/en/

Business Wire
www.businesswire.com

Last updated on: 04/09/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.